murine head blood vessels
3D imaging of the blood vessels of a mouse head using X-ray computer tomography and the newly developed contrast agent "XlinCA"

Image: Willy Kuo, UZH

News • Increased usability and precision

New X-ray contrast agent enhances vascular imaging

Researchers at the University of Zurich have developed a new X-ray contrast agent which is easier to use and distributes into all blood vessels more reliably, increasing the precision of vascular imaging.

This reduces the number of animals required in research experiments. Various diseases in humans and animals – such as tumors, strokes or chronic kidney disease – damage the blood vessels. Capillaries, the smallest blood vessels in the body, are particularly affected. The large surface area of the capillary network enables oxygen to be exchanged between the blood and the surrounding tissue, such as the muscles when we exercise or the brain when we think.

Without years of experience using the right injection techniques, the capillaries are often only partially filled, or missing entirely. Up to a quarter of the resulting images are therefore unusable

Willy Kuo

For the diagnosis and treatment of cardiovascular and other diseases, it is important to know the three-dimensional structure of blood vessels. This knowledge of the exact anatomy of the capillaries in humans and animals is also crucial for basic research. It enables researchers to investigate diseases that attack the blood vessels and evaluate new treatments. Researchers at the University of Zurich (UZH), the National Centre of Competence in Research Kidney.CH and the Biomaterials Science Center of the University of Basel have now developed a novel X-ray contrast agent called “XlinCA”, with which capillaries can be made visible much more precisely using computer tomography.

Previously, contrast agents were added to polymerizing plastic resins before they were injected into the blood vessels of euthanized animals. However, it is very difficult to completely fill out the delicate capillaries in various organs with viscous resins. “Without years of experience using the right injection techniques, the capillaries are often only partially filled, or missing entirely. Up to a quarter of the resulting images are therefore unusable,” says Willy Kuo, a postdoctoral researcher at the Institute of Physiology of UZH. By using “XlinCA” instead of other contrast agents, up to 25 percent fewer animals would be needed for experiments, states Kuo.

Recommended article

Photo

Article • In the brain

Gadolinium deposition: A real threat or a phantom debate?

The European Medicines Agency (EMA) decided to suspend authorisation for certain linear gadolinium agents. The review by the Committee for Medicinal Products for Human Use (CHMP) states: “There is currently no evidence that gadolinium deposition in the brain has caused any harm to patients; however EMA has recommended restrictions and suspensions for some intravenous linear agents in order to…

The basic problem with conventional methods is that plastic and water do not mix. This results in water inclusions where the contrast agent is absent, which causes disconnected vessel segments on the X-ray image. While the water-soluble X-ray contrast agents used in medicine may not have this problem, they cannot be solidified and leak through blood vessel walls into the surrounding tissue within minutes.

Contrast agents for medical use in humans consist of small molecules and are relatively simple to produce. “A custom contrast agent for ex vivo use was significantly more difficult to synthesize, since it is made up of polymers – molecules bonded together in long chains,” says Bernhard Spingler, professor at UZH’s Department of Chemistry. “XlinCA” has several advantages over previously used X-ray contrast agents: It is easy to use and enables complete and uninterrupted vascular imaging. It also allows multiple organs or even whole animals such as mice to be examined at the same time.


Source: University of Zurich

26.05.2020

Related articles

Photo

News • Diagnostic imaging reseach

How contrast agents disperse inside cells

A research team has investigated how contrast agents disperse inside cells. This could improve the assessment and further development of these agents and contribute to future medical diagnostics.

Photo

News •

Philips partners with the Stockholm County Council

Royal Philips today announced that it has signed a partnership agreement with the Stockholm County Council (SCC) to jointly innovate in health care.

Photo

Article • Diagnostic imaging

Contrast agents: useful, but controversial

Many procedures in diagnostic imaging would be impossible without contrast agents: they open up insights into vascular structures, show stenoses, inflammations, aneurysms and more. However, reports…

Related products

Subscribe to Newsletter